Both levosimendan and dobutamine treatments result in significant reduction of NT-proBNP levels, but levosimendan has better and prolonged neurohormonal effects than dobutamine.

Cavusoglu, Yuksel; Tek, Mujgan; Birdane, Alparslan; Ata, Necmi; Demirustu, Canan; Gorenek, Bulent; Unalir, Ahmet; Timuralp, Bilgin

Cavusoglu, Yuksel; Tek, Mujgan; Birdane, Alparslan; Ata, Necmi; Demirustu, Canan; Gorenek, Bulent; Unalir, Ahmet; Timuralp, Bilgin.

Int J Cardiol ; 127(3): e188-91, 2008 Jul 21.

Article in En | MEDLINE | ID: mdl-17884200

Subject(s)

Dobutamine/administration & dosage; Hydrazones/administration & dosage; Natriuretic Peptide, Brain/blood; Peptide Fragments/blood; Protein Precursors/blood; Pyridazines/administration & dosage; Humans; Neurotransmitter Agents/blood; Simendan; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Protein Precursors / Pyridazines / Natriuretic Peptide, Brain / Dobutamine / Hydrazones Limits: Humans Language: En Journal: Int J Cardiol Year: 2008 Document type: Article Country of publication: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links